Son K, Mukherjee M, McIntyre B, Eguez J, Radford K, LaVigne N, et al. Improved recovery of functionally active eosinophils and neutrophils using novel immunomagnetic technology. J Immunol Methods. 2017;449:44-55 pubmed publisher

Madge P, Maggioni A, Pascolutti M, Amin M, Waespy M, Bellette B, et al. Structural characterisation of high affinity Siglec-2 (CD22) ligands in complex with whole Burkitt's lymphoma (BL) Daudi cells by NMR spectroscopy. Sci Rep. 2016;6:36012 pubmed publisher

Hudson S, Herrmann H, Du J, Cox P, Haddad E, Butler B, et al. Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression. J Clin Immunol. 2011;31:1045-53 pubmed publisher

Nutku E, Aizawa H, Hudson S, Bochner B. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood. 2003;101:5014-20 pubmed

Kikly K, Bochner B, Freeman S, Tan K, Gallagher K, D alessio K, et al. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol. 2000;105:1093-100 pubmed